authors
- Chowdhury, Ishmum
- Ezenna, Chidubem
- Nouri, Armin
- Rossi, Raiza
- Akman, Zafer
- Abdulla A. Damluji, MD, PhD
- Michael Nanna, MD, MHS
- Chi, Kuan-Yu
- Chang, Yu
- Lee, Pei-Lun
- Torrado, Juan
- Cader, F Aaysha
- Mangalesh, Sridhar
- Shah, Priyansh
- Alper, Adir
Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Patients Undergoing PCI on Dual Antiplatelet Therapy: A Retrospective Cohort Study.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- May 15, 2026
published in
has subject area
- Aged
- Aspirin
- Coronary Artery Disease
- Dual Anti-Platelet Therapy
- Female
- Hemorrhage
- Humans
- Male
- Middle Aged
- Percutaneous Coronary Intervention
- Platelet Aggregation Inhibitors
- Purinergic P2Y Receptor Antagonists
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Selective Serotonin Reuptake Inhibitors
- Time Factors
- Treatment Outcome